Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma Clinical Trials in Jacksonville, Florida

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy